Jessica Piggee
About Jessica Piggee
Jessica Piggee serves as the Vice President of Clinical Research at OneOncology, a position she has held since 2024. With extensive experience in clinical research, she has previously worked at notable organizations such as Vanderbilt, Sarah Cannon, Mirati Therapeutics, and Genentech.
Work at OneOncology
Jessica Piggee serves as the Vice President of Clinical Research at OneOncology, a position she has held since 2024. In this role, she is responsible for overseeing clinical research initiatives and strategies within the organization. OneOncology focuses on providing comprehensive cancer care and advancing research to improve patient outcomes. Her tenure at OneOncology is marked by her commitment to enhancing clinical research methodologies and fostering collaborations that drive innovation in oncology.
Previous Experience in Clinical Research
Before joining OneOncology, Jessica Piggee accumulated extensive experience in clinical research across various organizations. She worked at Mirati Therapeutics as the Director of Clinical Research Collaborations from 2021 to 2024. Prior to that, she held multiple roles at Sarah Cannon, including Senior Manager of Clinical Operations and Site Management Organization Business Manager. Her career also includes a significant tenure at Vanderbilt, where she managed the HEM/BMT Clinical Research Program from 2011 to 2016.
Education and Expertise
Jessica Piggee holds a Master of Public Health (M.P.H.) degree in Epidemiology from Boston University School of Public Health, which she completed from 2000 to 2002. She also earned a Bachelor of Science (B.S.) degree in Biology from the University of North Carolina at Chapel Hill, where she studied from 1995 to 1999. Her educational background provides her with a strong foundation in public health and biological sciences, contributing to her expertise in clinical research.
Career Timeline
Jessica Piggee's career in clinical research spans over two decades, beginning in 2002 at Sarah Cannon as a Senior Manager in the Drug Development Unit. She transitioned to various roles, including Senior Alliance and Partnerships Leader at Genentech from 2019 to 2021. After her time at Mirati Therapeutics, she joined OneOncology in 2024. Her career trajectory reflects a consistent focus on clinical research and operational leadership within the oncology sector.